In a nutshell The study evaluated the effectiveness of three exercise programs in improving quality of life (QOL), pain, and lymphedema among breast cancer (BC) survivors. The study found that joint mobility exercise (JME) combined with progressive resistance exercise (PRE) showed promising results in improving QOL and lymphedema after BC...
Read MoreTreatment(s) now being considered-Radical mastectomy Posts on Medivizor
Does exercise increase recovery in patients undergoing surgery for breast cancer?
In a nutshell This study was carried out to examine the impact of physical activity (PA) on the recovery of patients having surgery for breast cancer (BC). The authors found that PA reduces the risk of patients developing chronic pain and women who had higher levels of PA recovered better than sedentary women. Some background BC is one of...
Read MoreEvaluating the best timing of surgery after chemotherapy in patients with breast cancer
In a nutshell This study evaluated the impact of different times after chemotherapy until breast cancer surgery on complications after surgery and survival outcomes. The data showed the optimal time to surgery (TTS) was between 21 and 28 days after chemotherapy in these patients. Some background Breast cancer (BC) is one of...
Read MoreIs nab-paclitaxel a better option than standard solvent-based taxanes for women with breast cancer?
In a nutshell This study explored whether nanoparticle albumin-bound (nab) paclitaxel (Abraxane) is more efficient as chemotherapy before surgery compared to solvent-based (sb) taxanes in patients with breast cancer. The authors found that nab-paclitaxel was able to improve the outcomes of these patients. Some background Breast cancer...
Read MoreEvaluating breast removal surgery in stage IV inflammatory breast cancer.
In a nutshell This study looked at the use of modified radical mastectomy (MRM) in the treatment of newly diagnosed stage IV inflammatory breast cancer (IBC). The authors found that MRM is associated with improved survival in these patients. Some background IBC is a rare and aggressive cancer that affects 2.0-2.5% of women with BC....
Read MoreCan circulating tumor cells help in improving the outcomes of patients with breast cancer?
In a nutshell This study evaluated the role of circulating tumor cells (CTCs) in deciding adjuvant therapy (AT; treatment after surgery) in patients with breast cancer (BC). This study showed that personalized AT based on CTCs improved patient survival. Some background BC that has not spread to other areas of the body is called non-metastatic...
Read MoreEvaluating radiation therapy after breast removal surgery for node-positive triple-negative breast cancer.
In a nutshell This study was carried out to assess the use of radiotherapy (RT) after mastectomy (surgical removal of the breast) for triple-negative breast cancer (TNBC) that has spread to the lymph nodes. The authors found that RT after surgery was associated with improved survival in patients with larger tumors. Some background Triple-negative...
Read MoreComparing breast-conserving surgery and breast-removal surgery after chemotherapy in patients with breast cancer
In a nutshell This study compared the effectiveness of breast-conserving surgery (BCS) to mastectomy (breast-removal surgery) after chemotherapy in patients with breast cancer. The authors found that BCS does not result in a lower survival in these patients. Some background BC is one of the most common forms of cancer in women. Standard care...
Read MoreDoes the addition of human endostatin to chemotherapy before surgery benefit patients with stage III breast cancer?
In a nutshell This trial was carried out to examine the use of recombinant human (rh) endostatin (EN) with CT before surgery in patients with breast cancer (BC). The authors concluded that the addition of EN to CT significantly improved the response rate to therapy and survival in these patients. Some background BC is the most common form of...
Read MoreDoes it matter how much healthy tissue is removed during surgery for patients with breast cancer who received chemotherapy first?
In a nutshell This study examined if there was a difference in patients with breast cancer first treated with chemotherapy that had a wide or narrow margin of healthy tissue removed during surgery. The results showed that the outcomes were similar regardless of how much healthy tissue was removed. Some background Traditionally, mastectomy (the...
Read MoreAdding targeted therapy to chemotherapy and surgery in patients with breast cancer
In a nutshell This study wanted to find out if adding targeted therapies to chemotherapy before surgery improved outcomes in patients with breast cancer. The study found that patients responded to treatment better when a targeted therapy was added to chemotherapy and surgery treatment. Some background There are multiple ways to treat breast...
Read MoreComparing letrozole and taselisib against letrozole and placebo before surgery in early stage breast cancer
In a nutshell This study aimed to investigate the combination of letrozole and taselisib as a neoadjuvant treatment (before surgery) in patients with hormone receptor-positive, HER2-negative, early stage breast cancer. This study concluded that this treatment...
Read More